Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	15.61	198.17	171.42
Graham Fair Price	-16.85	44.82	53.91
PEG	24.42	-1.99	1.60
Price/Book	-5.86	11.45	12.17
Price/Cash Flow	-70.47	186.97	-633.21
Prices/Earnings	55.20	70.12	45.18
Price/Sales	14.44	56.32	49.21
Price/FCF	-70.47	186.97	-633.21
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-0.86	0.79	0.80
Operating Margin	4.69	0.23	0.22
ROA	-37.64	0.03	0.04
ROE	0.07	0.04	-39.34
ROIC	0.05	0.04	-21.44
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.04	-0.03	-45.24
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.16	-0.08	53.49
EPS QOQ	0.28	-0.35	24.75
FCF QOQ	-1.47	4.42	200.68
Revenue QOQ	0.03	-0.12	276.45
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	104.64	113.21	8.19
Days Sales Outstanding (DSO)	58.07	51.65	-11.05
Inventory Turnover	0.86	0.79	-7.57
Debt/Capitalization	0.09	0.08	-9.41
Quick Ratio	0.88	0.99	12.51
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	43.80	46.76	6.77
Cash	8.36	10.85	29.77
Capex	-0.27	-0.25	5.41
Free Cash Flow	-0.84	2.86	240.40
Revenue	10.83	9.51	-12.18
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.29	1.86	43.95
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-0.95	-2.10	-120.00
Naive Interpretation	Member

06 - Financial Health · Weak

Rating